Vertex Pharmaceuticals (VRTX) Treasury Shares (2018 - 2019)

Vertex Pharmaceuticals' Treasury Shares history runs 16 years deep, the most recent figure standing at $2.5 million for Q4 2025.

• In Q4 2025, Treasury Shares fell 5.28% year-over-year to $2.5 million; the TTM figure through Dec 2025 stood at $2.5 million (down 5.28% YoY), while the FY2025 annual figure was $2.5 million, down 5.28% from the prior year.
• Treasury Shares for Q4 2025 stood at $2.5 million, down from $2.7 million in the prior quarter.
• The five-year high for Treasury Shares was $3.0 million in Q4 2023, with the low at $2.5 million in Q4 2025.
• The 5-year median for Treasury Shares is $2.9 million (2021), against an average of $2.8 million.
• The sharpest annual moves came in 2021 and 2024: Treasury Shares increased 6.87% in 2021, then declined 9.25% in 2024.
• Vertex Pharmaceuticals' Treasury Shares stood at $2.9 million in 2021, then rose by 0.14% to $2.9 million in 2022, then climbed by 1.68% to $3.0 million in 2023, then decreased by 9.25% to $2.7 million in 2024, then fell by 5.28% to $2.5 million in 2025.
• Business Quant data shows VRTX's Treasury Shares at $2.5 million in Q4 2025, $2.7 million in Q4 2024, and $3.0 million in Q4 2023.